These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14481568)

  • 1. Effect of aldosterone antagonist (SC 9420) on periodic paralysis.
    OKINAKA S; OHSAWA N; SHIZUME K; MOTOHASHI K; FUJITA T; MURAKAWA S; MATSUZAKI F; MORII H; UCHIKAWA T
    J Clin Endocrinol Metab; 1962 May; 22():549-51. PubMed ID: 14481568
    [No Abstract]   [Full Text] [Related]  

  • 2. Periodic paralysis with response to spironolactone.
    POSKANZER DC; KERR DN
    Lancet; 1961 Sep; 2(7201):511-3. PubMed ID: 13737365
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diuretic and saluretic action of an aldosterone antagonist (spirolactone, SC-9420) associated with an iso-indoline derivative (Hygroton) in refractory cardiac edema].
    STRATA A; PREIS H
    Boll Soc Ital Cardiol; 1962; 7():106-14. PubMed ID: 13917659
    [No Abstract]   [Full Text] [Related]  

  • 4. [Observations on the effect of the aldosterone antagonist spironolactone (aldactone) in normal and toxemic pregnancy (preliminary report)].
    RICHTER RH; ARNOLD M
    Gynaecologia; 1961; 152():248-57. PubMed ID: 14492054
    [No Abstract]   [Full Text] [Related]  

  • 5. [RENAL CLEARANCE OF FREE ALDOSTERONE BEFORE AND AFTER APPLICATION OF AN ALDOSTERONE ANTAGONIST].
    GFELLER J
    Z Gesamte Exp Med; 1964 Oct; 138():353-65. PubMed ID: 14316605
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of an aldosterone-antagonist (SC-8109) on radio-sodium (Na22) metabolism in rats with hypothalamic lesions.
    LUPULESCU A; NICOLESCU-CATARGIA ; NEACSUC
    Acta Biol Med Ger; 1961; 6():482-90. PubMed ID: 14467462
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the influence of an aldosterone antagonist (SC-8109) on the absorption of sodium from the gastrointestinal tract of rats].
    MOLL HC; KOCZOREK KR
    Klin Wochenschr; 1962 Aug; 40():825-7. PubMed ID: 14475194
    [No Abstract]   [Full Text] [Related]  

  • 8. Spironolactone in hypertensive patients. Oligemic and antihypertensive effects.
    GEORGOPOULOS AJ; DUSTAN H; PAGE IH
    Arch Intern Med; 1961 Sep; 108():389-92. PubMed ID: 13704490
    [No Abstract]   [Full Text] [Related]  

  • 9. [Aldosterone-antagonistic spirolactones. Principles for their indication and use].
    KOCZOREK KR
    Internist (Berl); 1961 Nov; 2():640-54. PubMed ID: 14457621
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of aldosterone-antagonist, SC 8109, on the secretion of aldosterone in normal rats.
    SINGER B
    Endocrinology; 1959 Sep; 65():512-4. PubMed ID: 14447060
    [No Abstract]   [Full Text] [Related]  

  • 11. [Aldosterone-antagonistic spirolactones. II. Clinical aspects].
    HILD R; KRUECK F
    Klin Wochenschr; 1961 Feb; 39():178-81. PubMed ID: 13714208
    [No Abstract]   [Full Text] [Related]  

  • 12. [The aldosterone-antagonistic spirolactone. I. Pharmacology].
    KRUECK F; HILD R
    Klin Wochenschr; 1960 Oct; 38():962-5. PubMed ID: 13754545
    [No Abstract]   [Full Text] [Related]  

  • 13. [Spirolactone, an aldosterone-antagonistic steroid. Illustration of its effects on a patient with liver cirrhosis].
    EILERSEN P; HEMPEL-JORGENSEN P
    Ugeskr Laeger; 1960 Feb; 122():252-6. PubMed ID: 13819718
    [No Abstract]   [Full Text] [Related]  

  • 14. [A study of the natriuretic action of an antagonist of aldosterone: spirolactone SC 9420 (aldactone)].
    VEYRAT R; ENGEL E; DUCOMMUN P; MULLER AF
    Schweiz Med Wochenschr; 1960 Apr; 90():494-7. PubMed ID: 13842023
    [No Abstract]   [Full Text] [Related]  

  • 15. EFFECT OF AN ALDOSTERONE ANTAGONIST (SPIRONOLACTONE) ON PATIENTS WITH SEVERE CONGESTIVE HEART FAILURE.
    CARRUTHERS BM; LEDRAY RD; SERAGLIA M; MCINTOSH HW; WALSH GC
    Can Med Assoc J; 1963 Sep; 89(13):633-41. PubMed ID: 14077808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [EFFECT OF AN ALDOSTERONE ANTAGONIST IN THERAPY RESISTANT EDEMAS].
    BARTOS V; KVASNICKA J; GROH J; ERBEN J
    Z Gesamte Inn Med; 1964 Jul; 19():588-91. PubMed ID: 14232020
    [No Abstract]   [Full Text] [Related]  

  • 17. Significance of aldosterone antagonism in the treatment of edema and ascites.
    GANTT CL; ECKLUND RE
    Am J Med; 1962 Oct; 33():490-500. PubMed ID: 13946423
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aldactone (aldosterone antagonist SC-9, 420) in the treatment of the edemas of heart patients and cirrhotic patients. Bioclinical study].
    PAGET M; LANGERON L; CROCCEL L; ROUTIER G; CROCCEL E; PROTIN M
    J Sci Med Lille; 1962 May; 80():225-35. PubMed ID: 14483183
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of anti-aldosterone drugs on periodic paralysis of the extremities and amyotonia].
    OKINAKA S
    Naika; 1962 Mar; 9():475-82. PubMed ID: 14481572
    [No Abstract]   [Full Text] [Related]  

  • 20. [ON THE ANTIHYPERTENSIVE EFFECT OF THE SUBSTANCES ISOBUTYLHYDROCHLOROTHIAZIDE, SPIRONOLACTONE AND TRIAMTERENE ACTING ON ELECTROLYTES].
    LAAS H; BETZIEN G; BRANCHRZ H
    Klin Wochenschr; 1963 Oct; 41():961-7. PubMed ID: 14092949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.